◼ Archived
Business
🔮 fades ✓
A ‘Transformative’ Narcolepsy Drug Opens New Opportunities in Neuroscience
The pharmaceutical company Takeda has released Phase 3 data for oveporexton, a transformative drug targeting narcolepsy type 1 symptoms.